Antiretroviral treatment (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress HIV, stop the progression of the disease and reduce HIV related morbidity and mortality. The benefits of ART also include the prevention of HIV transmission. In 2013, WHO launched new Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.
Treatment 2.0 is a WHO/UNAIDS initiative that aims to catalyze HIV treatment scale up, promoting innovation, efficiency, and sustainability through focused work in five priority areas: 1) optimized ARV drug regimens; 2) point of care technology for diagnosis and monitoring; 3) cost reduction; 4) adaptation of delivery systems and 5) community mobilization and participation in the continuum of HIV care. WHO/UNAIDS are working with global and regional partners, technical experts, civil society and other UN co-sponsors to implement this initiative in countries, with short-, medium- and long -term targets and milestones.
PAHO/WHO Scientific and Technical Material
- Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children Recommendations for a public health approach. Supplement; December 2014
- Antiretroviral Treatment in the Spotlight A Public Health Analysis in Latin America and the Caribbean; 2014
PAHO/WHO Mandates and Strategies
- HIV programme: Achieving our goals Operational plan 2014–2015
- Global health sector strategy on HIV/AIDS 2011-2015 WHO 2011
External Parties Material
PAHO/WHO Multimedia Materials
- World Health Organization HIV/AIDS Homepage
- The Joint United Nations Programme on HIV/AIDS (UNAIDS)
- UNAIDS Latin America
- Brazilian STI, Aids and Viral Hepatitis Department